0000000000609324

AUTHOR

José Luis Trillo-mata

showing 3 related works from this author

Predictability of pharmaceutical spending in primary health services using Clinical Risk Groups

2014

Background: Risk adjustment instruments applied to existing electronic health records and administrative datasets may contribute to monitoring the correct prescribing of medicines. Objective: We aim to test the suitability of the model based on the CRG system and obtain specific adjusted weights for determined health states through a predictive model of pharmaceutical expenditure in primary health care. Methods: A database of 261,054 population in one health district of an Eastern region of Spain was used. The predictive power of two models was compared. The first model (ATC-model) used nine dummy variables: sex and 8 groups from 1 to 8 or more chronic conditions while in the second model (…

MaleECONOMIA APLICADAHealth StatusPopulationContext (language use)Pharmacy expenditureDrug CostsSex FactorsDrug TherapyDummy variablePrimary healthMedicineHumansPredictabilityeducationeducation.field_of_studyActuarial scienceModels StatisticalPrimary Health Carebusiness.industryHealth PolicyClinical Risk GroupsAge FactorsECONOMIA SOCIOLOGIA Y POLITICA AGRARIATest (assessment)Risk adjustmentOne HealthSpainChronic DiseasePredictive powerFemalebusinessWHO-ATC-Code
researchProduct

Análisis de las prescripciones potencialmente inadecuadas en centros sociosanitarios según los criterios START

2021

Resumen Antecedentes y objetivo La prescripcion potencialmente inadecuada de un farmaco por omision se define como la no utilizacion de farmacos que si estan clinicamente indicados. El objetivo de este articulo es analizar y describir la evolucion de las prescripciones inadecuadas por omision en los residentes de los centros sociosanitarios de un departamento de salud. Material y metodos Estudio descriptivo observacional retrospectivo realizado en los centros sociosanitarios del departamento de salud Valencia-Clinico-Malvarrosa durante el periodo 2016-2018. Se incluyeron todos los pacientes institucionalizados durante este periodo. Se evaluo la prevalencia de prescripciones potencialmente i…

03 medical and health sciencesAging0302 clinical medicineMedicine (miscellaneous)030212 general & internal medicine030204 cardiovascular system & hematologyGeriatrics and GerontologyRevista Española de Geriatría y Gerontología
researchProduct

Cost of Type 2 Diabetes Patients with Chronic Kidney Disease Based on Real-World Data: An Observational Population-Based Study in Spain

2021

[EN] This study analyzed the prevalence, costs and economic impact of chronic kidney disease CKD in patients with T2D in a Spanish Health District using real-world data. Observational cross-sectional study in adult patients with T2D was through data extracted from the information systems of the Valencia Clinico-La Malvarrosa Health District in the year 2015. Patients were stratified with the KDIGO classification for CKD. Additionally, patients were assigned to Clinical Risk Groups (CRGs) according to multimorbidity. Direct costs of primary and specialized care, and medication were estimated. The prevalence of T2D in the database population (n = 28,345) was 10.8% (mean age (SD) = 67.8 years …

Malehealthcare resourcesmedicine.medical_specialtyECONOMIA APLICADAHealth Toxicology and MutagenesisPopulationRenal functioncostsType 2 diabetesDiseaseArticleIndirect costsChronic kidney diseaseInternal medicineHealth caremedicineHumansRenal Insufficiency ChronicHealthcare resourcesBurden of careeducationAgededucation.field_of_studyDiabetisbusiness.industryClinical Risk GroupsPublic Health Environmental and Occupational HealthRType 2 diabetesHealth Care Costsmedicine.diseaseCostsKDIGO classificationCross-Sectional StudiesDiabetes Mellitus Type 2Spainburden of careInsuficiència renal crònicaMedicineFemaleObservational studyECONOMIA FINANCIERA Y CONTABILIDADtype 2 diabetesbusinesschronic kidney diseaseKidney diseaseInternational Journal of Environmental Research and Public Health
researchProduct